ArticleJournal of the National Comprehensive Cancer Network : JNCCN2023

Hormone Receptor-Positive Breast Cancer Sensitive to Pembrolizumab: Evidence of the Pathogenicity of the MLH1 Variant 1835del3.

Henry G Kaplan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.